Divestra 2/0.035mg Tablet

Divestra 2/0.035mg Tablet is a combination medication containing cyproterone & ethinyl estradiol. Cyproterone is an antiandrogen, while ethinyl estradiol is a synthetic form of estrogen. Together, they work to regulate hormonal imbalances and are commonly used in the treatment of conditions such as hirsutism (excessive hair growth), acne, androgenetic alopecia (male-pattern baldness), and polycystic ovary syndrome (PCOS). This combination medication helps in suppressing the production of androgens (male hormones) and balancing estrogen levels in the body.

Ingredients:

• Cyproterone: Acts as an antiandrogen by blocking the effects of androgens such as testosterone. It helps in reducing symptoms of androgen excess such as hirsutism and acne.
• Ethinyl Estradiol: This synthetic estrogen assists in regulating the menstrual cycle and balancing hormone levels. When combined with cyproterone, it offers contraceptive effects and further aids in hormonal balance.

Uses:

Divestra 2/0.035mg Tablet is prescribed for the following conditions:

1. Hirsutism: It helps in reducing excessive hair growth (hirsutism) in women by suppressing androgen activity and promoting a more feminine pattern of hair growth.
2. Acne: Divestra can improve acne symptoms by reducing sebum production and inhibiting the formation of acne lesions associated with hormonal imbalances.
3. Androgenetic Alopecia: It may be used to treat female-pattern baldness (androgenetic alopecia) by counteracting the effects of androgens on hair follicles and promoting hair regrowth.
4. Polycystic Ovary Syndrome (PCOS): Divestra is sometimes prescribed to manage symptoms of PCOS, such as irregular menstrual cycles, ovarian cysts, and hormonal imbalances.

Dosage:

The dosage of Divestra 2/0.035mg Tablet may vary depending on the specific condition being treated and individual patient response. It is typically taken orally once daily, preferably at the same time each day, with or without food.

Side Effects:

While generally well-tolerated, Divestra 2/0.035mg Tablet may cause some side effects, including:

1. Nausea and Vomiting: Some individuals may experience gastrointestinal upset, including nausea, vomiting, or abdominal discomfort.
2. Headache: Mild to moderate headaches may occur in some patients.
3. Breast Tenderness: Temporary breast tenderness or enlargement may occur due to changes in hormone levels.
4. Irregular Bleeding: Some women may experience irregular bleeding or spotting, particularly during the first few months of treatment.

Precautions:

To ensure safe and effective use of Divestra 2/0.035mg Tablet, consider the following precautions:

1. Pregnancy and Breastfeeding: It is contraindicated during pregnancy and breastfeeding due to the potential risk of harm to the fetus or nursing infant. Effective contraception should be used during treatment with Divestra.
2. Liver Function: Patients with impaired liver function should use Divestra with caution, as it may affect liver enzymes and metabolism.
3. Thromboembolic Disorders: Use of Divestra may increase the risk of thromboembolic events such as blood clots, particularly in women with a history of thromboembolic disorders.

Contraindications:

Divestra 2/0.035mg Tablet is contraindicated in individuals with a history of hypersensitivity to cyproterone, ethinyl estradiol, or any other components of the tablet. It should not be used in patients with certain medical conditions such as liver disease, breast cancer, or thromboembolic disorders.